![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Hospital Universitari de Bellvitge Wyeth |
---|---|
Information provided by: | Hospital Universitari de Bellvitge |
ClinicalTrials.gov Identifier: | NCT00396721 |
To test in a pilot trial the efficacy and tolerance of sirolimus oral (at low doses) in patient to treat poor-prognosis IgA Nephropathy.
Condition | Intervention | Phase |
---|---|---|
Glomerulonephritis, IGA Nephropathy, IGA IGA Nephropathy |
Drug: sirolimus |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Pilot Trial of Treatment of Poor-Prognosis Iga Nephropathy With Low Exposure to Sirolimus. |
Estimated Enrollment: | 20 |
Study Start Date: | January 2006 |
Estimated Study Completion Date: | November 2006 |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Josep M. Cruzado, Medical Doctor | 0034932607602 | 27541jcg@comb.es |
Spain, Barcelona | |
Nephrology Department. Hospital Universitari de Bellvitge | Recruiting |
L'Hospitalet de Llobregat, Barcelona, Spain, 08907 | |
Contact: Josep M Cruzado, Medical Doctor 0034932607602 27541jcg@comb.es |
Study Chair: | Josep M Cruzado, Medical Doctor | Nephrlogy Department. Hospital Universitari de Bellvitge |
Study ID Numbers: | SIREPNA/05, 2005-002610-37 |
Study First Received: | November 3, 2006 |
Last Updated: | November 20, 2006 |
ClinicalTrials.gov Identifier: | NCT00396721 |
Health Authority: | Spain: Ministry of Health |
Nephropathy, IGA Pilot trial Sirolimus Rapamune |
Sirolimus Glomerulonephritis Autoimmune Diseases Urologic Diseases Clotrimazole Miconazole |
Nephritis Tioconazole Berger disease Glomerulonephritis, IGA Kidney Diseases |
Anti-Bacterial Agents Anti-Infective Agents Immunologic Factors Immune System Diseases Antineoplastic Agents Antifungal Agents |
Therapeutic Uses Physiological Effects of Drugs Antibiotics, Antineoplastic Immunosuppressive Agents Pharmacologic Actions |